VERAXA
LIVE

Serial Number

90784943

Owner

VERAXA BIOTECH GMBH

Attorney

Michael J. Leonard

Filing Date

Jun 21, 2021

Add to watchlist:

No watchlists yet
View on USPTO

VERAXA Trademark

Serial Number: 90784943 • Registration: 7282793

VERAXA is a trademark filed by VERAXA BIOTECH GMBH on June 21, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

VERAXA BIOTECH GMBH (2 trademarks)

Carl-Friedrich-Gauß-Ring 5
HEIDELBERG 69124 , DE

Entity Type: 99

Velabs Therapeutics GmbH

Meyerhofstraße 1
Heidelberg 69117 , DE

Entity Type: 99

Trademark Details

Filing Date

June 21, 2021

Registration Date

January 23, 2024

Published for Opposition

February 21, 2023

Goods & Services

Opto-electronic apparatus and instruments and downloadable and recorded computer software and microfluid chips for conducting antibody, peptide or high-throughput active agent search with small inorganic or organic molecules for scientific research purposes

Antibodies and the chemical modifications and conjugates thereof for medical diagnosis and treatment purposes and medical laboratory tests for medical diagnosis and treatment purposes; Immunoglobulins for medical use for the treatment and prevention of disease; Vaccines; Structural proteins in the nature of proteins in raw material form and protein arrays for medical diagnosis and treatment purposes; Veterinary preparations, namely, anti-cancer medication, anti-inflammatory medication, anti-pain medication in cream, powder, tablet and injectable form; Medical preparations, namely, diagnostic preparations, therapeutic preparations for medical use in the nature of anti-cancer medication, anti-inflammatory medication, anti-pain medication in cream, powder, tablet and injectable form; Pharmaceutical preparations, namely, anti-cancer preparations, anti-inflammatory preparations, anti-pain preparations, metabolic preparations for treating diabetes and obesity in cream, powder, tablet, and injectable form

Antibodies and the chemical modifications and conjugates thereof for medical research purposes and medical laboratory tests for medical research purposes; Immunoglobulins for medical research use; Structural proteins in the nature of proteins in raw material form and protein arrays for medical research purposes

Medical services; Medical diagnosis tests, monitoring and reporting and medical screening services in the nature of medical active agent search services; Medical screening services in the nature of medical combing and medical active agent search of antibodies originating from patients; Personal medical information services

Medical opto-electronic apparatus and instruments for conducting antibody, peptide or high-throughput active agent search with small inorganic or organic molecules for medical diagnosis and treatment purposes

Scientific research conducted using high-throughput active agent search and bioinformatics methods; Drug discovery services; Research and testing services in the field of antibody active agent search services for scientific research purposes; Research, testing, and development services in the field of antibody modification and conjugate services for scientific research purposes; Research and testing services in the field of vaccine search services for scientific research purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 13, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 13, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 13, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 13, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 13, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 13, 2024 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 23, 2024 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Dec 14, 2023 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 14, 2023 AITU
NOTICE OF ALLOWANCE CANCELLED
Nov 15, 2023 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Nov 15, 2023 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 14, 2023 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Oct 2, 2023 TMBN
OPPOSITION TERMINATED NO. 999999
Oct 2, 2023 OP.T
OPPOSITION DISMISSED NO. 999999
Oct 2, 2023 OP.D
OPPOSITION INSTITUTED NO. 999999
Aug 21, 2023 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 23, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 17, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 17, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 17, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 17, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 3, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 3, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 3, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2022 CRFA
ASSIGNED TO LIE
Aug 25, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 29, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 2, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2021 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 21, 2021 ASGN
NEW APPLICATION ENTERED
Jun 24, 2021 NWAP